ANI PHARMACEUTICALS INC Total Revenue

• ANI PHARMACEUTICALS INC showed an increase of +43.8% in Total Revenue from 2024 to 2025.
• This data is from ANI PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 27, 2026.
• XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2013: $7.84 million | Q1 2014: $10.90 million | Q2 2014: $6.65 million | Q3 2014: $17.39 million | Q4 2014: $21.04 million | Q1 2015: $18.80 million | Q2 2015: $19.52 million | Q3 2015: $19.97 million | Q4 2015: $18.04 million | Q1 2016: $20.56 million | Q2 2016: $31.34 million | Q3 2016: $38.53 million | Q4 2016: $38.21 million | Q1 2017: $36.63 million | Q2 2017: $44.76 million | Q3 2017: $48.16 million | Q4 2017: $47.29 million | Q1 2018: $46.48 million | Q2 2018: $47.27 million | Q3 2018: $50.70 million | Q4 2018: $57.12 million | Q1 2019: $52.89 million | Q1 2019: $52.89 million | Q2 2019: $54.36 million | Q2 2019: $54.36 million | Q3 2019: $51.34 million | Q3 2019: $51.34 million | Q4 2019: $47.97 million | Q4 2019: $47.97 million | Q1 2020: $49.77 million | Q1 2020: $49.77 million | Q2 2020: $48.47 million | Q3 2020: $52.98 million | Q4 2020: $57.25 million | Q1 2021: $54.52 million | Q2 2021: $48.63 million | Q3 2021: $52.06 million | Q1 2022: $64.48 million | Q2 2022: $73.86 million | Q3 2022: $83.82 million | Q1 2023: $106.79 million | Q2 2023: $116.55 million | Q3 2023: $131.83 million | Q1 2024: $137.43 million | Q2 2024: $138.04 million | Q3 2024: $148.33 million | Q1 2025: $197.12 million | Q2 2025: $211.37 million | Q3 2025: $227.81 million.
• Over the full 19 years of available data (2009 to 2025), ANI PHARMACEUTICALS INC's Total Revenue has grown by 70,116.9%.
• Historical annual values: Fiscal year 2025: $883.37 million | Fiscal year 2024: $614.38 million | Fiscal year 2023: $486.82 million | Fiscal year 2022: $316.39 million | Fiscal year 2021: $216.14 million | Fiscal year 2020: $208.48 million | Fiscal year 2019: $206.55 million | Fiscal year 2019: $206.55 million | Fiscal year 2018: $201.58 million | Fiscal year 2018: $201.58 million | Fiscal year 2017: $176.84 million | Fiscal year 2016: $128.62 million | Fiscal year 2015: $76.32 million | Fiscal year 2014: $55.97 million | Fiscal year 2013: $30.08 million | Fiscal year 2012: $20.37 million | Fiscal year 2011: $435.2 thousand | Fiscal year 2010: $2.47 million | Fiscal year 2009: $1.26 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026